Table 1. Baseline characteristics of participants.
AML = acute myeloid leukemia.
| Characteristic | Number of patients (%) (n = 20) |
| Gender | |
| Male | 15 (75%) |
| Female | 5 (25%) |
| Race | |
| Malay | 12 (60%) |
| Chinese | 5 (25%) |
| Indian | 1 (5%) |
| Others | 2 (10%) |
| Medical history | |
| Diabetes mellitus | 10 (50%) |
| Cancer | 1 (5%) - AML |
| Chronic kidney failure | 11 (55%) |
| Recurrent urinary tract infection | 1 (5%) |
| Chronic obstructive airway disease | 1 (5%) |
| History of antimicrobial exposure in hospital within the past 3 months | |
| Cephalosporins | 7 |
| B-lactam and inhibitor combination | 14 |
| Quinolones | 2 |
| Macrolides | 4 |
| Clindamycin | 1 |
| Penicillin | 2 |
| Sulfa drugs | 2 |